chr2-47408556-G-C
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PP1PM2_SupportingPVS1
This summary comes from the ClinGen Evidence Repository: The NM_000251.3:c.366+1G>C variant is in the dinucleotide of canonical donor splice site of exon 2, and predicted by SpliceAI to cause exon 2 skipping leading to a frameshift, p.(Ala72Phefs*9) (PVS1 met). Segregation analysis of pedigree data shows odds of pathogenicity = 3.23 (Australian Colon Cancer Family Registry) (>2.08; PP1 met). The variant is absent in gnomAD v2.1, v3.1 and v4.1 (PM2_Supporting met). Therefore, this variant meets the criteria to be classified as Likely Pathogenic. (VCEP specifications version 1) LINK:https://erepo.genome.network/evrepo/ui/classification/CA346730170/MONDO:0007356/137
Frequency
Consequence
NM_000251.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
- Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MSH2 | TSL:1 MANE Select | c.366+1G>C | splice_donor intron | N/A | ENSP00000233146.2 | P43246-1 | |||
| MSH2 | TSL:1 | c.366+1G>C | splice_donor intron | N/A | ENSP00000384199.1 | E9PHA6 | |||
| MSH2 | c.366+1G>C | splice_donor intron | N/A | ENSP00000588166.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 31
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at